• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

    199.92 -4.06 (-1.99%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 594,443
    Open 202.37
    Bid (Size) 196.00 (400)
    Ask (Size) 208.00 (1,400)
    Prev. Close 203.98
    Today's Range 198.68 - 205.17
    52wk Range 97.50 - 207.48
    Shares Outstanding 62,311,104
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks
    Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    3 Overrated Stocks with Warning Signs
    The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos... 
    Via StockStory

    Performance

    YTD
    +15.5%
    +15.5%
    1 Month
    +9.2%
    +9.2%
    3 Month
    +20.9%
    +20.9%
    6 Month
    +47.3%
    +47.3%
    1 Year
    +71.7%
    +71.7%

    More News

    Read More
    News headline image
    3 Reasons to Sell JAZZ and 1 Stock to Buy Instead
    Via StockStory
    News headline image
    Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’
    Via MarketMinute
    JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) Beats Q4 Estimates but 2026 Guidance Tempers Gains ↗
    Via Chartmill
    News headline image
    The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
    Via Finterra
    Topics Economy Initial Public Offering Intellectual Property
    News headline image
    1 Value Stock to Research Further and 2 We Ignore
    Via StockStory
    News headline image
    3 Healthcare Stocks Walking a Fine Line
    Via StockStory
    News headline image
    Zymeworks (ZYME) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
    Via StockStory
    Topics Artificial Intelligence Supply Chain
    News headline image
    Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales
    Via StockStory
    News headline image
    Jazz Pharmaceuticals Earnings: What To Look For From JAZZ
    Via StockStory
    Topics Artificial Intelligence Government World Trade
    News headline image
    1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
    Via StockStory
    News headline image
    1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid
    Via StockStory
    News headline image
    3 Cash-Producing Stocks We Think Twice About
    Via StockStory
    News headline image
    $100 Million Exit: Why One Fund Walked Away From a Chinese E-Commerce Stock Up 24% ↗
    Via The Motley Fool
    Topics Economy
    News headline image
    This Bank Stock Just Saw a $24 Million Fund Sale, but Here's Why It's Still a Top Holding ↗
    Via The Motley Fool
    Topics Credit Cards ETFs
    News headline image
    Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed? ↗
    Via The Motley Fool
    Topics Initial Public Offering Intellectual Property
    News headline image
    3 of Wall Street’s Favorite Stocks We Think Twice About
    Via StockStory
    News headline image
    3 Small-Cap Stocks That Fall Short
    Via StockStory
    Topics Electric Vehicles
    News headline image
    Reflecting On Pharmaceuticals Stocks’ Q3 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ)
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    3 Mid-Cap Stocks with Warning Signs
    Via StockStory
    News headline image
    3 Reasons JAZZ is Risky and 1 Stock to Buy Instead
    Via StockStory
    Topics Bankruptcy
    News headline image
    3 Value Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
    Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
    What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
    Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
    The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
    What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
    The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 199.92
    When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
    The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 04/29/26 04:00 PM ET
    What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
    The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 12.46B
    How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
    Jazz Pharmaceuticals plc - Ordinary Shares has 12B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.